[ad_1]
President Trump and President-elect Joe Biden both celebrated the news that a coronavirus vaccine developed by Pfizer and BioNTech has been shown to be over 90% effective in preventing COVID-19 in their phase clinical trial 3.
The development is an important step towards tackling the global pandemic at a time when many regions are experiencing an increase in cases.
BIDEN CORONAVIRUS TEAM TO INCLUDE RICK BRIGHT, HHS OFFICIAL OUSTED HHS
“THE SCHOLARSHIP MARKET IS GROWING, A VACCINE TO COME. 90% EFFICIENT REPORT. SUCH GREAT NEWS! Trump tweeted Monday morning.
Biden also celebrated the success of the lawsuit, but also warned that the pandemic remained an issue and likely will continue to be for months.
“I congratulate the brilliant women and men who helped make this breakthrough and gave us such reason to hope,” Biden said in a statement. “At the same time, it is also important to understand that the end of the battle against COVID-19 is still months away. The news follows a schedule previously announced by industry officials that called for vaccine approval by the end of November. Even if this is achieved and some Americans are vaccinated later this year, it will be several more months before vaccination becomes widespread in this country.
Biden then reminded Americans to continue to wear masks and practice social distancing and other preventative measures.
UNITED STATES NEARLY 10M CORONAVIRUS CASES IN SURGE INFECTIONS WITH THESE MOST DIFFICULT STATES
The vaccine requires two doses and the trial, which began July 27, included 38,955 participants who received the second dose on Sunday.
Executives at Pfizer and BioNTech celebrated their breakthrough as a cause for hope.
“Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provide initial evidence of our vaccine’s ability to prevent COVID-19, ”Pfizer Chairman and CEO Dr. Albert Bourla said in a statement. “We are reaching this crucial milestone in our vaccine development program at a time when the world needs it most, with infection rates setting new records, hospitals close to overcapacity and economies struggling to reopen.” With today’s news, we are an important step in providing people around the world with a much needed breakthrough to help end this global health crisis.
CLICK HERE TO GET THE FOX NEWS APP
BioNTech CEO and co-founder Ugur Sahin called the trial result a “victory for innovation, science and a global collaborative effort,” and that “in the midst of a second wave and a lot of us locked out, we appreciate even more how important this milestone is on our way to ending this pandemic and for us all to regain a sense of normalcy.
The companies plan to produce up to 50 million doses of the vaccine this year and up to 1.3 billion next year.
[ad_2]
Source link